CLINICAL STUDIES UNDER WAY

HELP US LEARN MORE: YOUNG PEOPLE NEEDED FOR READING STUDY


The Yale Center for Dyslexia & Creativity is currently recruiting 10-16 yr. old children and adolescents to participate in two unique studies designed to evaluate the effectiveness of medication on reading and attention.

These studies are funded by the Lilly Company, to examine the effectiveness of atomoxetine (Strattera) on reading in children and adolescents who have difficulty reading, with or without attention problems. Strattera is currently approved by the FDA for the treatment of attention disorder (ADHD).  Preliminary studies suggest that atomoxetine may also be helpful in improving reading.

One of the studies also examines brain activation patterns using fMRI during reading and attention tasks. Over 1000 children and adolescents have participated in the fMRI studies at the Center examining reading and attention. Children and adolescents who have metal, e.g., braces, are not eligible to participate in the fMRI but may be eligible for the companion study which does not involve MRI.

Children and adolescents who are good readers are also being recruited to help interpret the results in children with dyslexia. These good readers will not receive medication but will receive the full academic testing.

The program encompasses approximately 9 months and has been carefully designed to offer optimal monitoring of academic and behavioral progress.  An academic report with recommendations is provided at the end of the study, as well as compensation for expenses related to participating in the study.

To obtain detailed information
regarding participation, please call:
Karen (203) 764-9158

Copyright 2008, The Yale Center for Dyslexia & Creativity • Yale School of Medicine